Security key
71722W107
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)
CUSIP: 71722W107
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 78,837,943
- Total 13F shares
- 43,760,270
- Share change
- +982,744
- Total reported value
- $452,721,621
- Put/Call ratio
- 30%
- Price per share
- $10.37
- Number of holders
- 109
- Value change
- +$5,267,236
- Number of buys
- 63
- Number of sells
- 30
Report period
Q3 2023
Institutions
109
Top holders
10
PHAT full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
Phathom Pharmaceuticals, Inc. SEC filings
Phathom Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71722W107
Recent filing periods:
Top shareholders of PHAT - Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
13%
|
10,109,279
|
$144,764,875 | — | 30 Jun 2023 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
|
Company |
4.8%
|
3,760,869
|
$53,855,644 | — | 30 Jun 2023 | |
| Carlyle Group Inc. |
13F
|
Company |
4.4%
|
3,496,808
|
$50,074,291 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
4.2%
|
3,332,137
|
$47,716,202 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
2,002,632
|
$28,677,691 | — | 30 Jun 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
2.5%
|
1,949,700
|
$27,919,704 | — | 30 Jun 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
2.2%
|
1,757,127
|
$25,162,058 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
1,742,337
|
$24,950,265 | — | 30 Jun 2023 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.6%
|
1,287,500
|
$18,437,000 | — | 30 Jun 2023 | |
| NEA Management Company, LLC |
13F
|
Company |
1.6%
|
1,276,595
|
$18,280,840 | — | 30 Jun 2023 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.3%
|
1,060,605
|
$15,187,864 | — | 30 Jun 2023 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,049,675
|
$15,031,346 | — | 30 Jun 2023 | |
| Decheng Capital Management III (Cayman), LLC |
13F
|
Company |
1.1%
|
850,000
|
$12,172,000 | — | 30 Jun 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.89%
|
700,000
|
$10,024,000 | — | 30 Jun 2023 | |
| Newtyn Management, LLC |
13F
|
Company |
0.87%
|
683,648
|
$9,789,839 | — | 30 Jun 2023 | |
| Woodline Partners LP |
13F
|
Company |
0.85%
|
673,688
|
$9,647,212 | — | 30 Jun 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.83%
|
656,000
|
$9,393,920 | — | 30 Jun 2023 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.75%
|
592,388
|
$8,483,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.67%
|
529,843
|
$7,587,352 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.62%
|
490,123
|
$7,018,561 | — | 30 Jun 2023 | |
| StepStone Group LP |
13F
|
Company |
0.54%
|
422,085
|
$6,044,257 | — | 30 Jun 2023 | |
| MPM BioImpact LLC |
13F
|
Company |
0.36%
|
282,332
|
$4,042,994 | — | 30 Jun 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.32%
|
250,000
|
$3,580,000 | — | 30 Jun 2023 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.3%
|
237,935
|
$3,407,229 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.28%
|
217,186
|
$3,110,103 | — | 30 Jun 2023 | |
| Altium Capital Management LLC |
13F
|
Company |
0.26%
|
207,432
|
$2,970,426 | — | 30 Jun 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
200,000
|
$2,864,000 | — | 30 Jun 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
181,609
|
$2,600,640 | — | 30 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
178,870
|
$2,561,418 | — | 30 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.21%
|
163,956
|
$2,347,850 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
154,668
|
$2,214,846 | — | 30 Jun 2023 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.2%
|
154,250
|
$2,208,860 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.18%
|
140,280
|
$2,008,810 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
133,996
|
$1,918,823 | — | 30 Jun 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.16%
|
130,000
|
$1,861,600 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.14%
|
113,693
|
$1,628,084 | — | 30 Jun 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.12%
|
98,013
|
$1,403,546 | — | 30 Jun 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.11%
|
86,295
|
$1,235,744 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
78,587
|
$1,125,366 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
72,382
|
$1,036,511 | — | 30 Jun 2023 | |
| Swiss National Bank |
13F
|
Company |
0.09%
|
71,500
|
$1,023,880 | — | 30 Jun 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
70,803
|
$1,013,899 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
63,408
|
$908,003 | — | 30 Jun 2023 | |
| Penn Mutual Asset Management |
13F
|
Company |
0.08%
|
62,802
|
$899,325 | — | 30 Jun 2023 | |
| MOORE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.08%
|
60,000
|
$859,200 | — | 30 Jun 2023 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.07%
|
58,658
|
$840,000 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
56,082
|
$803,094 | — | 30 Jun 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
53,909
|
$772,000 | — | 30 Jun 2023 | |
| Atom Investors LP |
13F
|
Company |
0.07%
|
53,286
|
$763,056 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
50,205
|
$718,935 | — | 30 Jun 2023 |
Institutional Holders of Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) as of Q3 2023
As of 30 Sep 2023,
Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,760,270 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Carlyle Group Inc., Invesco Ltd., BlackRock Inc., VANGUARD GROUP INC, Ensign Peak Advisors, Inc, Avidity Partners Management LP, GILDER GAGNON HOWE & CO LLC, and NEA Management Company, LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
103
Q3 2023 holders
109
Holder diff
6
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.